Phase I dose-escalation study of the protein kinase C (PKC) inhibitor AEB071 in patients with metastatic uveal melanoma Meeting Abstract
| Authors: | Piperno-Neumann, S.; Kapiteijn, E.; Larkin, J. M. G.; Carvajal, R. D.; Luke, J. J.; Seifert, H.; Roozen, I.; Zoubir, M.; Yang, L.; Choudhury, S.; Yerramilli-Rao, P.; Hodi, F. S.; Schwartz, G. K. |
| Abstract Title: | Phase I dose-escalation study of the protein kinase C (PKC) inhibitor AEB071 in patients with metastatic uveal melanoma |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613204316 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.9030 |
| Notes: | Meeting Abstract: 9030 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
